Global Cell Expansion Market Outlook 2024-2029, featuring analysis of Thermo Fisher Scientific, Danaher Corp, Merck, Sartorius, Corning, and more

Global cell expansion market

DUBLIN, April 19, 2024 (Globe Newswire) — The “Global Cell Expansion Market Forecast to 2029” report has been added. ResearchAndMarkets.com Recruitment.

The global cell expansion market is projected to reach USD 26.7 billion by 2029 from an estimated USD 14.3 billion in 2024, at a CAGR of 13.3% during the forecast period 2024-2029. This market growth can be attributed to the increasing cell penetration rate. Chronic disease. The increasing prevalence of chronic diseases such as cancer has increased the need for cell-based therapies such as cell and gene therapy, tissue engineering, and regenerative medicine. The growing demand for innovative cell-based therapies and novel therapeutics is driving the need for cell proliferation. This trend is expected to drive the growth of the cell expansion market in the coming years.

By application segment, biopharmaceutical production segment will hold the largest share in 2023

In 2023, the biopharmaceutical production segment accounted for the largest share by application segment in the global cell expansion market. Biopharmaceutical production includes the production of monoclonal antibodies, vaccines, and other therapeutic proteins. Increasing investment and funding for the development of new medicines and growing demand for biological therapies such as monoclonal antibodies, vaccines, and therapeutic proteins are driving the growth of biopharmaceutical production in the cell expansion market.

The US will continue to dominate the cell expansion market during the forecast period 2024-2029

In 2023, the North American cell expansion market was dominated by the United States. The United States is the world’s largest biopharmaceutical market and a leader in biopharmaceutical research and investment. Additionally, the United States is home to some of the world’s leading academic research institutions, including Harvard University, Stanford University, and the Massachusetts Institute of Technology (MIT). These institutions conduct cutting-edge research in life sciences, including drug discovery and biotechnology, including the adoption of cell proliferation techniques, thereby driving market growth. Additionally, increasing funding in the field of tissue engineering and regenerative medicine is also driving the growth of the cell expansion market.

Research scope

This research report analyzes the cell expansion market by product (consumables and equipment), by cell type (human cells, animal cells, other cell types), and by application (biopharmaceutical production, tissue engineering and regenerative medicine, drug screening and development, and other applications), by end user (pharmaceutical and biotech companies, research and academic institutions, hospitals and diagnostic laboratories, and other end users), by region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa).

The scope of the report covers detailed information about key factors such as drivers, constraints, challenges, and opportunities influencing the growth of the Cell Expansion Market. A detailed analysis of key industry players has been conducted to provide insights into their business overview, products, solutions, key strategies, collaborations, partnerships, and agreements. It also includes new product launches, collaborations and acquisitions, and recent developments related to the cell expansion market.

story continues

List of introduced companies

• Thermo Fisher Scientific (USA)

• Danaher Corporation (USA)

• Merck KGaA (Germany)

• Sartorius AG (Germany)

• Corning Corporation (USA)

• Lonza (Switzerland)

• Terumo Corporation (Japan)

• Eppendorf SE (Germany)

• Fujifilm Corporation (Japan)

• Biotechne Inc. (USA)

• Repligen Inc. (USA)

• Getinge AB (Sweden)

• Miltenyi Biotech (Germany)

• PerkinElmer (USA)

• STEMCELL Technologies (Canada)

• PromoCell GmbH (Germany)

• High Media Laboratories (India)

• BD (USA)

• Takara Bio Co., Ltd. (Japan)

• Shanghai Taning Biological Technology Co., Ltd. (Japan)

• Repro Cell Co., Ltd. (Japan)

• PBS Biotech (USA)

• Acro Biosystems (USA)

• Solida Biotech GmbH (Germany)

• Beijing Cytonich Biotechnology Co., Ltd. (China)

• Neuromics (USA)

• Bionet (Spain)

• Ceresus (UK)

key attributes

premium insights

• Increasing attention to personalized medicine driving the market

• Consumables will hold the largest share in the Asia Pacific cell expansion market in 2023

• China will record the highest growth rate during the forecast period

• Pharmaceutical and biotech companies will hold the largest market share in 2023

Market trend

• driver

  • Increased incidence of chronic diseases

  • Increased government investment in cell-based research and treatments

  • Increasing attention to personalized medicine

  • Increase in GMP certification of cell therapy manufacturing facilities

  • Expanding strategic alliances for cell-based therapeutic development

• restraints

• opportunity

  • High growth opportunities in emerging markets

  • Increased usefulness of 3D cell expansion technology

  • Advances in automation in cell therapy manufacturing

• assignment

For more information about this report, please visit https://www.researchandmarkets.com/r/sps81c.

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source of international market research reports and market data. We provide the latest data on international and regional markets, key industries, top companies, new products and latest trends.

attachment

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900